ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

ASCO Entering Prime Of Life

May 31, 1991

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

NCAB To Hear Reports On Environmental Carcinogenesis, International Research Efforts

June 4, 1976